Clinical Trial

A Dose Optimization Study of Enzalutamide in Elderly Patients With Advanced Prostate Cancer

Name: A Dose Optimization Study of Enzalutamide in Elderly Patients With Advanced Prostate Cancer — clinical trial record (NCT07512076)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a phase II, single-centre, pragmatic, non-randomized, dose escalation study to evaluate optimal dose levels of enzalutamide in elderly patients using pharmacokinetic blood sampling concentrations.

Trial Details

NCT Number	NCT07512076
Lead Sponsor	Sunnybrook Health Sciences Centre
Conditions	Prostate Cancer Patients, Elderly Patients, Pharmacokinetic Study
Enrollment	26 participants
Start Date	2026-04
Primary Completion	2027-07 (estimated)
Study Completion	2027-12 (estimated)
Updated on ClinicalTrials.gov	2026-04-06